Medicinova MNOV Income Statement (2010-2026)

NASDAQ MNOV
$1.79 +0.04 (+2.29%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Medicinova Quarterly Income Statement

Periods 64 quarters
Latest Jun 2026

Medicinova reported revenue of $0.46M and net income of -$2.31M for the quarter ended Jun 2026. This income statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
48.92M49.03M49.04M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.22M49.22M
Revenue & cost
Revenue
0.04M1.00M0.13M0.12M0.15M0.46M
Gross Profit
0.02M0.01M0.00M0.32M
Operating items
Research & DevelopmentR&D
2.53M2.09M1.78M2.11M2.56M2.45M2.01M1.48M1.74M0.79M1.65M1.78M1.65M1.86M1.91M1.84M2.19M1.58M1.54M1.03M
Selling, General & AdministrativeSG&A
1.78M1.55M0.33M1.30M1.52M1.44M1.22M1.49M1.56M1.35M0.84M1.35M1.40M1.45M1.28M1.36M1.44M1.81M1.55M1.83M
Other Operating ExpensesOther Opex
0.12M0.12M0.15M0.14M
Operating ExpensesOpex
4.31M3.64M2.10M3.41M4.09M3.90M3.23M2.96M3.30M2.15M2.49M3.14M3.05M3.31M3.18M3.20M3.74M3.50M3.24M3.00M
Operating IncomeOp. Inc
-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M-2.54M
EBIT
-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M-2.54M
Non-operating items
Non Operating Interest Expenses
Non Operating Investment Income
Interest & Investment IncomeInt & Inv Inc
0.03M0.04M0.04M0.04M0.09M0.25M0.43M0.51M0.45M0.44M0.44M0.40M0.44M0.45M0.39M0.34M0.32M0.34M0.30M0.23M
Other Non Operating IncomeOther Non Op Inc.
-0.01M-0.01M-0.01M-0.01M-0.03M-0.01M-0.19M-0.46M-0.02M-0.01M-0.00M-0.02M-0.02M0.01M1.01M0.00M952.00-0.01M0.18M-0.00M
Net income details
EBT
-4.28M-3.57M-2.07M-3.37M-4.00M-3.64M-2.80M-2.45M-2.85M-0.71M-2.05M-2.74M-2.61M-2.86M-2.79M-2.87M-3.28M-3.04M-2.79M-2.31M
Tax ProvisionsTaxes
Profit After TaxPAT
-4.28M-3.58M-2.09M-3.39M-4.03M-3.66M-2.99M-2.92M-2.87M-0.73M-2.05M-2.75M-2.63M-2.85M-2.83M-2.86M-3.28M-3.05M-2.80M-2.31M
Income from Continuing OperationsIncome (Continuing)
-4.28M-3.57M-2.07M-3.37M-4.00M-3.64M-2.80M-2.45M-2.85M-0.71M-2.05M-2.74M-2.61M-2.86M-2.79M-2.87M-3.28M-3.04M-2.79M-2.31M
Consolidated Net IncomeConsol Net Inc.
-4.28M-3.57M-2.07M-3.37M-4.00M-3.64M-2.80M-2.45M-2.85M-0.71M-2.05M-2.74M-2.61M-2.86M-2.79M-2.87M-3.28M-3.04M-2.79M-2.31M
Income towards Parent CompanyParent Net Inc
-4.28M-3.57M-2.07M-3.37M-4.00M-3.64M-2.80M-2.45M-2.85M-0.71M-2.05M-2.74M-2.61M-2.86M-2.79M-2.87M-3.28M-3.04M-2.79M-2.31M
Net Income towards Common StockholdersNet Income
-4.28M-3.57M-2.07M-3.37M-4.00M-3.64M-2.80M-2.45M-2.85M-0.71M-2.05M-2.74M-2.61M-2.86M-2.79M-2.87M-3.28M-3.04M-2.79M-2.31M
Additional items
EPS (Basic)
-0.09-0.07-0.04-0.07-0.08-0.07-0.06-0.05-0.06-0.01-0.04-0.06-0.05-0.06-0.06-0.06-0.07-0.06-0.06-0.05
EPS (Diluted)
-0.09-0.07-0.04-0.07-0.08-0.07-0.06-0.05-0.06-0.01-0.04-0.06-0.05-0.06-0.06-0.06-0.07-0.06-0.06-0.05
Shares Outstanding
48.80M48.99M48.60M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.06M49.22M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
48.80M48.99M48.60M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.06M49.22M
EBITDA
-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M-2.54M
Interest ExpensesInt Expense
Tax Rate